1. Home
  2. INTG vs TVRD Comparison

INTG vs TVRD Comparison

Compare INTG & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intergroup Corporation (The)

INTG

Intergroup Corporation (The)

HOLD

Current Price

$27.85

Market Cap

38.9M

Sector

Real Estate

ML Signal

HOLD

TVRD

Tvardi Therapeutics Inc.

HOLD

Current Price

$4.55

Market Cap

37.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTG
TVRD
Founded
1965
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
37.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
INTG
TVRD
Price
$27.85
$4.55
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$51.67
AVG Volume (30 Days)
17.1K
146.8K
Earning Date
02-13-2026
02-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$65,385,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.82
N/A
52 Week Low
$9.57
$3.74
52 Week High
$42.50
$43.65

Technical Indicators

Market Signals
Indicator
INTG
TVRD
Relative Strength Index (RSI) 51.23 50.78
Support Level $25.00 $3.87
Resistance Level $28.40 $4.46
Average True Range (ATR) 1.92 0.28
MACD 0.32 0.16
Stochastic Oscillator 73.99 78.42

Price Performance

Historical Comparison
INTG
TVRD

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

About TVRD Tvardi Therapeutics Inc.

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

Share on Social Networks: